PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 1994 April; 93(4): 1756–1764.
PMCID: PMC294236

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.

Abstract

Hydrolysis of glucosylceramide by beta-glucocerebrosidase results in ceramide, a critical component of the intercellular lamellae that mediate the epidermal permeability barrier. A subset of type 2 Gaucher patients displays ichthyosiform skin abnormalities, as do transgenic Gaucher mice homozygous for a null allele. To investigate the relationship between glucocerebrosidase deficiency and epidermal permeability barrier function, we compared the stratum corneum (SC) ultrastructure, lipid content, and barrier function of Gaucher mice to carrier and normal mice, and to hairless mice treated topically with bromoconduritol B epoxide (BrCBE), an irreversible inhibitor of glucocerebrosidase. Both Gaucher mice and BrCBE-treated mice revealed abnormal, incompletely processed, lamellar body-derived sheets throughout the SC interstices, while transgenic carrier mice displayed normal bilayers. The SC of a severely affected type 2 Gaucher's disease infant revealed similarly abnormal ultrastructure. Furthermore, the Gaucher mice demonstrated markedly elevated transepidermal water loss (4.2 +/- 0.6 vs < 0.10 g/m2 per h). The electron-dense tracer, colloidal lanthanum, percolated between the incompletely processed lamellar body-derived sheets in the SC interstices of Gaucher mice only, demonstrating altered permeability barrier function. Gaucher and BrCBE-treated mice showed < 1% and < 5% of normal epidermal glucocerebrosidase activity, respectively, and the epidermis/SC of Gaucher mice demonstrated elevated glucosylceramide (5- to 10-fold), with diminished ceramide content. Thus, the skin changes observed in Gaucher mice and infants may result from the formation of incompetent intercellular lamellar bilayers due to a decreased hydrolysis of glucosylceramide to ceramide. Glucocerebrosidase therefore appears necessary for the generation of membranes of sufficient functional competence for epidermal barrier function.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (4.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Yardley HJ, Summerly R. Lipid composition and metabolism in normal and diseased epidermis. Pharmacol Ther. 1981;13(2):357–383. [PubMed]
  • Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 1991;24:1–26. [PubMed]
  • Siegenthaler U, Laine A, Polak L. Studies on contact sensitivity to chromium in the guinea pig. The role of valence in the formation of the antigenic determinant. J Invest Dermatol. 1983 Jan;80(1):44–47. [PubMed]
  • Landmann L. The epidermal permeability barrier. Anat Embryol (Berl) 1988;178(1):1–13. [PubMed]
  • Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol. 1992 Mar;98(3):279–289. [PubMed]
  • Hou SY, Mitra AK, White SH, Menon GK, Ghadially R, Elias PM. Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J Invest Dermatol. 1991 Feb;96(2):215–223. [PubMed]
  • Fartasch M, Bassukas ID, Diepgen TL. Structural relationship between epidermal lipid lamellae, lamellar bodies and desmosomes in human epidermis: an ultrastructural study. Br J Dermatol. 1993 Jan;128(1):1–9. [PubMed]
  • Lampe MA, Williams ML, Elias PM. Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res. 1983 Feb;24(2):131–140. [PubMed]
  • Cox P, Squier CA. Variations in lipids in different layers of porcine epidermis. J Invest Dermatol. 1986 Dec;87(6):741–744. [PubMed]
  • Holleran WM, Takagi Y, Imokawa G, Jackson S, Lee JM, Elias PM. beta-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation. J Lipid Res. 1992 Aug;33(8):1201–1209. [PubMed]
  • Chang F, Wertz PW, Squier CA. Comparison of glycosidase activities in epidermis, palatal epithelium and buccal epithelium. Comp Biochem Physiol B. 1991;100(1):137–139. [PubMed]
  • Chang F, Swartzendruber DC, Wertz PW, Squier CA. Covalently bound lipids in keratinizing epithelia. Biochim Biophys Acta. 1993 Jul 25;1150(1):98–102. [PubMed]
  • Elias PM, McNutt NS, Friend DS. Membrane alterations during cornification of mammalian squamous epithelia: a freeze-fracture, tracer, and thin-section study. Anat Rec. 1977 Dec;189(4):577–594. [PubMed]
  • Legler G, Bieberich E. Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F. Arch Biochem Biophys. 1988 Jan;260(1):437–442. [PubMed]
  • Stephens MC, Bernatsky A, Burachinsky V, Legler G, Kanfer JN. The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects. J Neurochem. 1978 May;30(5):1023–1027. [PubMed]
  • Hara A, Radin NS. Enzymic effects of beta-glucosidase destruction in mice. Changes in glucuronidase levels. Biochim Biophys Acta. 1979 Feb 1;582(3):423–433. [PubMed]
  • Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest. 1993 Apr;91(4):1656–1664. [PMC free article] [PubMed]
  • Ghadially R, Williams ML, Hou SY, Elias PM. Membrane structural abnormalities in the stratum corneum of the autosomal recessive ichthyoses. J Invest Dermatol. 1992 Dec;99(6):755–763. [PubMed]
  • Tybulewicz VL, Tremblay ML, LaMarca ME, Willemsen R, Stubblefield BK, Winfield S, Zablocka B, Sidransky E, Martin BM, Huang SP, et al. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature. 1992 Jun 4;357(6377):407–410. [PubMed]
  • BRADY RO, KANFER JN, SHAPIRO D. METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE. Biochem Biophys Res Commun. 1965 Jan 18;18:221–225. [PubMed]
  • Nilsson O, Svennerholm L. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem. 1982 Sep;39(3):709–718. [PubMed]
  • Nilsson O, Månsson JE, Håkansson G, Svennerholm L. The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease. Biochim Biophys Acta. 1982 Sep 14;712(3):453–463. [PubMed]
  • Goldblatt J, Beighton P. Cutaneous manifestations of Gaucher disease. Br J Dermatol. 1984 Sep;111(3):331–334. [PubMed]
  • Sidransky E, Sherer DM, Ginns EI. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res. 1992 Oct;32(4):494–498. [PubMed]
  • Sherer DM, Metlay LA, Sinkin RA, Mongeon C, Lee RE, Woods JR., Jr Congenital ichthyosis with restrictive dermopathy and Gaucher disease: a new syndrome with associated prenatal diagnostic and pathology findings. Obstet Gynecol. 1993 May;81(5 ):842–844. [PubMed]
  • Lui K, Commens C, Choong R, Jaworski R. Collodion babies with Gaucher's disease. Arch Dis Child. 1988 Jul;63(7):854–856. [PMC free article] [PubMed]
  • Lipson AH, Rogers M, Berry A. Collodion babies with Gaucher's disease--a further case. Arch Dis Child. 1991 May;66(5):667–667. [PMC free article] [PubMed]
  • Capecchi MR. The new mouse genetics: altering the genome by gene targeting. Trends Genet. 1989 Mar;5(3):70–76. [PubMed]
  • Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 1991 Jun 28;65(7):1153–1163. [PubMed]
  • Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res. 1991 Jul;32(7):1151–1158. [PubMed]
  • Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest. 1991 Oct;88(4):1338–1345. [PMC free article] [PubMed]
  • Beutler E, Kuhl W. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. J Lab Clin Med. 1970 Nov;76(5):747–755. [PubMed]
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. [PubMed]
  • Elias PM, Brown BE. The mammalian cutaneous permeability barrier: defective barrier function is essential fatty acid deficiency correlates with abnormal intercellular lipid deposition. Lab Invest. 1978 Dec;39(6):574–583. [PubMed]
  • Ponec M, Weerheim A, Kempenaar J, Mommaas AM, Nugteren DH. Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res. 1988 Jul;29(7):949–961. [PubMed]
  • Holleran WM, DeGregorio MW, Ganapathi R, Wilbur JR, Macher BA. Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cells. Cancer Chemother Pharmacol. 1986;17(1):11–15. [PubMed]
  • Bommannan D, Menon GK, Okuyama H, Elias PM, Guy RH. Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res. 1992 Aug;9(8):1043–1047. [PubMed]
  • Williams ML, Elias PM. From basket weave to barrier. Unifying concepts for the pathogenesis of the disorders of cornification. Arch Dermatol. 1993 May;129(5):626–629. [PubMed]
  • Williams ML, Elias PM. Stratum corneum lipids in disorders of cornification: increased cholesterol sulfate content of stratum corneum in recessive x-linked ichthyosis. J Clin Invest. 1981 Dec;68(6):1404–1410. [PMC free article] [PubMed]
  • Rizzo WB, Dammann AL, Craft DA. Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity. J Clin Invest. 1988 Mar;81(3):738–744. [PMC free article] [PubMed]
  • Williams ML, Koch TK, O'Donnell JJ, Frost PH, Epstein LB, Grizzard WS, Epstein CJ. Ichthyosis and neutral lipid storage disease. Am J Med Genet. 1985 Apr;20(4):711–726. [PubMed]
  • Lee RE, Worthington CR, Glew RH. The bilayer nature of deposits occurring in Gaucher's disease. Arch Biochem Biophys. 1973 Nov;159(1):259–266. [PubMed]
  • White SH, Mirejovsky D, King GI. Structure of lamellar lipid domains and corneocyte envelopes of murine stratum corneum. An X-ray diffraction study. Biochemistry. 1988 May 17;27(10):3725–3732. [PubMed]
  • Pascher I, Lundmark M, Nyholm PG, Sundell S. Crystal structures of membrane lipids. Biochim Biophys Acta. 1992 Dec 11;1113(3-4):339–373. [PubMed]
  • Curatolo W. The physical properties of glycolipids. Biochim Biophys Acta. 1987 Jun 24;906(2):111–136. [PubMed]
  • Man MQ, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol. 1993 Jun;129(6):728–738. [PubMed]
  • Menon GK, Grayson S, Elias PM. Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis. J Invest Dermatol. 1986 May;86(5):591–597. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation